Chondrosarcoma Cancer from Detection to Treatment
What Is Chondrosarcoma?
Chondrosarcoma is a malignant bone cancer that arises from cartilage-producing cells.
It mostly affects adults between 30–60 years and is the second most common primary bone cancer | after osteosarcoma.
It usually develops in:
• Pelvis
• Femur | thigh bone
• Humerus | upper arm
• Ribs
• Shoulder blade
Unlike osteosarcoma or Ewing’s sarcoma, chondrosarcoma grows slowly and is less responsive to chemotherapy and radiation, making surgery the main treatment.
Chondrosarcoma is a malignant bone cancer that arises from cartilage-producing cells.
It mostly affects adults between 30–60 years and is the second most common primary bone cancer | after osteosarcoma.
It usually develops in:
• Pelvis
• Femur | thigh bone
• Humerus | upper arm
• Ribs
• Shoulder blade
Unlike osteosarcoma or Ewing’s sarcoma, chondrosarcoma grows slowly and is less responsive to chemotherapy and radiation, making surgery the main treatment.
1. Initial Evaluation
Common Symptoms:
• Dull, persistent pain at the tumor site
• Swelling or lump in the affected area
• Limited joint movement or stiffness
• Pain at rest or at night
• Pathological fracture
Risk Factors:
• Prior radiation exposure
• Genetic mutations | IDH1, IDH2
• Preexisting benign cartilage tumors:
Ollier disease | enchondromatosis
Maffucci syndrome
Common Symptoms:
• Dull, persistent pain at the tumor site
• Swelling or lump in the affected area
• Limited joint movement or stiffness
• Pain at rest or at night
• Pathological fracture
Risk Factors:
• Prior radiation exposure
• Genetic mutations | IDH1, IDH2
• Preexisting benign cartilage tumors:
Ollier disease | enchondromatosis
Maffucci syndrome
2. Physical Examination
• Swelling, tenderness, or visible deformity
• Decreased limb movement
• Signs of nerve or vascular compression
If symptoms persist | 6 weeks ➧ imaging is ordered immediately.
• Swelling, tenderness, or visible deformity
• Decreased limb movement
• Signs of nerve or vascular compression
If symptoms persist | 6 weeks ➧ imaging is ordered immediately.
3. Imaging and Scanning Tests
X-ray
Shows calcifications | popcorn or ring-and-arc pattern.
Bone destruction with cortical expansion or thinning.
Magnetic Resonance Imaging
Shows soft tissue extension and involvement of nearby structures.
Best imaging for surgical planning.
CT Scan
Defines bone destruction and mineralization pattern.
Helps plan biopsy and surgery.
Bone Scan | PET-CT
Detects metastasis.
Used for staging and follow-up.
X-ray
Shows calcifications | popcorn or ring-and-arc pattern.
Bone destruction with cortical expansion or thinning.
Magnetic Resonance Imaging
Shows soft tissue extension and involvement of nearby structures.
Best imaging for surgical planning.
CT Scan
Defines bone destruction and mineralization pattern.
Helps plan biopsy and surgery.
Bone Scan | PET-CT
Detects metastasis.
Used for staging and follow-up.
4. Biopsy | Definitive Diagnosis
Types:
Core needle biopsy
Open surgical biopsy
Microscopic Findings:
Malignant cartilage cells in a matrix with varying calcification.
Grading based on cellular atypia and mitotic activity.
Types:
Core needle biopsy
Open surgical biopsy
Microscopic Findings:
Malignant cartilage cells in a matrix with varying calcification.
Grading based on cellular atypia and mitotic activity.
5. Grading System | Histologic Grade
Grade 1 | Low
Slight atypia, slow-growing
Locally aggressive, rare metastasis
Grade 2 | Intermediate
More cellular, mild atypia
May metastasize
Grade 3 | High
Highly cellular, marked atypia
High metastatic potential
The higher the grade, the greater the risk of spread and recurrence.
Grade 1 | Low
Slight atypia, slow-growing
Locally aggressive, rare metastasis
Grade 2 | Intermediate
More cellular, mild atypia
May metastasize
Grade 3 | High
Highly cellular, marked atypia
High metastatic potential
The higher the grade, the greater the risk of spread and recurrence.
6. Staging | AJCC / TNM System
I - Low-grade, localized
II - High-grade, localized
III - Multiple lesions in same bone
IV - Distant metastasis
I - Low-grade, localized
II - High-grade, localized
III - Multiple lesions in same bone
IV - Distant metastasis
7. Multidisciplinary Care Team
• Orthopedic oncologist
• Medical oncologist
• Radiation oncologist
• Radiologist
• Pathologist
• Physiotherapist and rehabilitation team
• Psychologist / nutritionist
• Orthopedic oncologist
• Medical oncologist
• Radiation oncologist
• Radiologist
• Pathologist
• Physiotherapist and rehabilitation team
• Psychologist / nutritionist
8. Treatment Pathway
➛ Surgery
Purpose:
Complete tumor removal with wide, clean margins | R0 resection.
Wide Excision / En Bloc Resection
Entire tumor removed with a margin of healthy tissue.
Limb-Sparing Surgery
Reconstruction using metal prosthesis or bone graft.
Amputation
Only if limb-sparing is not possible or tumor involves major nerves/vessels.
Pelvic Resection
For tumors in the pelvic bones.
➛ Radiation Therapy
Used when:
Surgery cannot remove the entire tumor.
Tumor is inoperable.
High-grade chondrosarcomas.
Modern options:
Proton therapy or intensity-modulated radiation for better precision.
➛ Chemotherapy
Generally ineffective for conventional chondrosarcoma.
Used only for aggressive subtypes:
• Mesenchymal chondrosarcoma
• Dedifferentiated chondrosarcoma
Common regimens:
Doxorubicin + Ifosfamide
Cisplatin + Doxorubicin
➛ Targeted and Experimental Therapies
IDH1/IDH2 inhibitors
mTOR inhibitors
Immunotherapy trials for metastatic or unresectable disease
➛ Surgery
Purpose:
Complete tumor removal with wide, clean margins | R0 resection.
Wide Excision / En Bloc Resection
Entire tumor removed with a margin of healthy tissue.
Limb-Sparing Surgery
Reconstruction using metal prosthesis or bone graft.
Amputation
Only if limb-sparing is not possible or tumor involves major nerves/vessels.
Pelvic Resection
For tumors in the pelvic bones.
➛ Radiation Therapy
Used when:
Surgery cannot remove the entire tumor.
Tumor is inoperable.
High-grade chondrosarcomas.
Modern options:
Proton therapy or intensity-modulated radiation for better precision.
➛ Chemotherapy
Generally ineffective for conventional chondrosarcoma.
Used only for aggressive subtypes:
• Mesenchymal chondrosarcoma
• Dedifferentiated chondrosarcoma
Common regimens:
Doxorubicin + Ifosfamide
Cisplatin + Doxorubicin
➛ Targeted and Experimental Therapies
IDH1/IDH2 inhibitors
mTOR inhibitors
Immunotherapy trials for metastatic or unresectable disease
9. Supportive and Rehabilitation Care
➛ Pain management with NSAIDs or opioids
➛ Physical therapy after surgery for mobility restoration
➛ Prosthetic training | if limb amputation
➛ Nutritional support to enhance recovery
➛ Psychological counseling for coping and emotional wellbeing
➛ Pain management with NSAIDs or opioids
➛ Physical therapy after surgery for mobility restoration
➛ Prosthetic training | if limb amputation
➛ Nutritional support to enhance recovery
➛ Psychological counseling for coping and emotional wellbeing
10. Follow-up and Monitoring
After Treatment:
Every 3 months for first 2 years
Every 6 months for next 3 years
Annually after 5 years
Monitoring Includes:
Physical exam
MRI/CT of the operated site
Chest CT/X-ray | for lung metastasis
Bone scan or PET-CT if recurrence suspected
After Treatment:
Every 3 months for first 2 years
Every 6 months for next 3 years
Annually after 5 years
Monitoring Includes:
Physical exam
MRI/CT of the operated site
Chest CT/X-ray | for lung metastasis
Bone scan or PET-CT if recurrence suspected
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page